Trial Search Results

Composite Health Assessment Risk Model (CHARM) for Older Adults (BMT CTN 1704)

Prospective observational multicenter study of allogeneic Hematopoietic Stem Cell Transplantation (HCT) in recipients 60 years and older to assess important determinants of health status to be combined into a composite health risk model to improve risk assessment of non-relapse mortality (NRM).

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Center for International Blood and Marrow Transplant Research

Collaborator: National Institutes of Health (NIH)

Stanford Investigator(s):


  • Diagnostic Test: Age 60+ with planned HCT for Hematologic Malignancy


Inclusion Criteria:

   1. Subject is > 60.0 years old at time of enrollment.

   2. Hematological malignancy as an indication for allogeneic transplantation.

   3. Eligible for allogeneic transplantation based on institutional standards

   4. First allogeneic transplant planned. Any conditioning regimen and allogeneic donor is

   5. Able to speak and read English. Spanish, and Mandarin will be acceptable when sites
   have ability to perform healthcare provider tests in those languages.

   6. Written informed consent

Exclusion Criteria:

1. Prior allogeneic HCT

Ages Eligible for Study

60 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Melanie Gaudinez
Not Recruiting